{{Redirect|Polik}}
{{Drugbox
| verifiedrevid = 461766483
| IUPAC_name = 1,2,4-Trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene
| image = Haloprogin.svg
| image2 =

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US_comment = Not available
| legal_status =
| routes_of_administration = [[Topical medication|Topical]]

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 777-11-7
| ATC_prefix = D01
| ATC_suffix = AE11
| PubChem = 3561
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00793
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3440
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = AIU7053OWL
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00339
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1289

<!--Chemical data-->
| C=9 | H=4 | Cl=3 | I=1 | O=1
| molecular_weight = 361.39 g/mol
| smiles = Clc1cc(OCC#CI)c(Cl)cc1Cl
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C9H4Cl3IO/c10-6-4-8(12)9(5-7(6)11)14-3-1-2-13/h4-5H,3H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CTETYYAZBPJBHE-UHFFFAOYSA-N
| melting_point = 113.5
| solubility = Insoluble
}}

'''Haloprogin''' is an [[Antifungal medication|antifungal]] drug used to treat [[athlete's foot]] and other [[fungus|fungal]] [[infection]]s.  It is marketed in creams under the trade names '''Halotex''', '''Mycanden''', '''Mycilan''', and '''Polik'''.

==Action==
Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed [[Over-the-counter drug|over-the-counter]] primarily to treat [[tinea]] infections of the [[skin]]. The mechanism of action is unknown.<ref>{{cite web
| last =
| first =
| authorlink =
| vauthors =
| title =Haloprogin
| work =Drugs@FDA
| publisher =[[Food and Drug Administration]]
| date =
| url = http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=HALOTEX
| format =
| doi =
| accessdate = 2007-02-17 }}</ref>

Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.<ref>{{cite web
| last =
| first =
| authorlink =
| vauthors =
| title = Haloprogin
| work = DrugBank
| publisher = University of Alberta
| date =Nov 6, 2006
| url =http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD01011.txt
| format =
| doi =
| accessdate = 2007-02-17 }}</ref>

==References==
<references/>

{{Antifungals}}
{{Xenobiotic-sensing receptor modulators}}

[[Category:Alkynes]]
[[Category:Antifungals]]
[[Category:Chloroarenes]]
[[Category:Organoiodides]]

{{antiinfective-drug-stub}}
{{dermatologic-drug-stub}}